Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carly J Paoli

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Advances in Therapy|November 21, 2015
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with HyperlipidemiaHenry J Henk, Carly J Paoli, Shravanthi R Gandra
Critical Care Medicine|August 16, 2019
The authors replyCarly J Paoli, Mark A Reynolds, Matthew Gitlin, et al.
Critical Care Medicine|July 27, 2018
Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity LevelCarly J Paoli, Mark A Reynolds, Meenal Sinha, et al.
Clinical Therapeutics|September 27, 2014
Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment systemJames L Pirkle, Carly J Paoli, Greg Russell, et al.
Critical Care Explorations|March 14, 2020
Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual AnalysisCarly J Paoli, Mark A Reynolds, Courtney Coles, et al.
Journal of Health Economics and Outcomes Research|March 19, 2024
Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic OutcomesCarly J Paoli, Jörg Linder, Khushboo Gurjar, et al.
Journal of Oncology Practice|April 20, 2013
Health care costs for patients with cancer at the end of lifeBenjamin Chastek, Carolyn Harley, Joel Kallich, et al.
Pulmonary Therapy|September 6, 2025
Real-World Adherence and Persistence of Upfront Therapy in Patients with Pulmonary Arterial Hypertension in the United StatesTeresa De Marco, Carly J Paoli, Nicole S Croteau, et al.
Respiratory Medicine|April 24, 2025
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertensionCarly J Paoli, Chang Zhang, Xiaoqin Tang, et al.
Pulmonary Circulation|March 12, 2026
Time to Therapy Activation and Initial Combination Therapy (TITANIC) for Patients With Pulmonary Arterial HypertensionCyrus Kholdani, Carly J Paoli, Tyler Peck, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Advances in Therapy|November 21, 2015
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with HyperlipidemiaHenry J Henk, Carly J Paoli, Shravanthi R Gandra
Critical Care Medicine|August 16, 2019
The authors replyCarly J Paoli, Mark A Reynolds, Matthew Gitlin, et al.
Critical Care Medicine|July 27, 2018
Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity LevelCarly J Paoli, Mark A Reynolds, Meenal Sinha, et al.
Clinical Therapeutics|September 27, 2014
Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment systemJames L Pirkle, Carly J Paoli, Greg Russell, et al.
Critical Care Explorations|March 14, 2020
Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual AnalysisCarly J Paoli, Mark A Reynolds, Courtney Coles, et al.
Journal of Health Economics and Outcomes Research|March 19, 2024
Effectiveness of Single-Tablet Combination Therapy in Improving Adherence and Persistence and the Relation to Clinical and Economic OutcomesCarly J Paoli, Jörg Linder, Khushboo Gurjar, et al.
Journal of Oncology Practice|April 20, 2013
Health care costs for patients with cancer at the end of lifeBenjamin Chastek, Carolyn Harley, Joel Kallich, et al.
Pulmonary Therapy|September 6, 2025
Real-World Adherence and Persistence of Upfront Therapy in Patients with Pulmonary Arterial Hypertension in the United StatesTeresa De Marco, Carly J Paoli, Nicole S Croteau, et al.
Respiratory Medicine|April 24, 2025
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertensionCarly J Paoli, Chang Zhang, Xiaoqin Tang, et al.
Pulmonary Circulation|March 12, 2026
Time to Therapy Activation and Initial Combination Therapy (TITANIC) for Patients With Pulmonary Arterial HypertensionCyrus Kholdani, Carly J Paoli, Tyler Peck, et al.
Pageof 3